The main research interests are the development and clinical translation of novel diagnostic and therapeutic radiotracers in the field of oncology including neuroendocrine tumors.
Selected Publications
Beck, Julia, Siebenhüner, Alexander, Endocrine-Related Cancer, 31(3). https://doi.org/10.1530/ERC-23-0235
, Christ, Emanuel, & Refardt, Julie. (2024). Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms.
Beck, Julia, Siebenhüner, Alexander, Endocrine-Related Cancer, 31(3). https://doi.org/10.1530/ERC-23-0235
, Christ, Emanuel, & Refardt, Julie. (2024). Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms.
Eigler, Christopher, McDougall, Lisa, Bauman, Andreas, Bernhardt, Peter, Hentschel, Michael, Blackham, Kristine A., Nicolas, Guillaume, Fani, Melpomeni, Journal of Nuclear Medicine, 65(4), 573–579. https://doi.org/10.2967/jnumed.123.266817
, & Cordier, Dominik. (2024). Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study.
Eigler, Christopher, McDougall, Lisa, Bauman, Andreas, Bernhardt, Peter, Hentschel, Michael, Blackham, Kristine A., Nicolas, Guillaume, Fani, Melpomeni, Journal of Nuclear Medicine, 65(4), 573–579. https://doi.org/10.2967/jnumed.123.266817
, & Cordier, Dominik. (2024). Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study.
Fricke, Julia, Westerbergh, Frida, McDougall, Lisa, Favaretto, Chiara, Christ, Emanuel, Nicolas, Guillaume P., Geistlich, Susanne, Borgna, Francesca, Fani, Melpomeni, Bernhardt, Peter, van der Meulen, Nicholas P., Müller, Cristina, Schibli, Roger, & European Journal of Nuclear Medicine and Molecular Imaging, 51, 2517–2519. https://doi.org/10.1007/s00259-024-06641-w
. (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([ 161 Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum.
Fricke, Julia, Westerbergh, Frida, McDougall, Lisa, Favaretto, Chiara, Christ, Emanuel, Nicolas, Guillaume P., Geistlich, Susanne, Borgna, Francesca, Fani, Melpomeni, Bernhardt, Peter, van der Meulen, Nicholas P., Müller, Cristina, Schibli, Roger, & European Journal of Nuclear Medicine and Molecular Imaging, 51, 2517–2519. https://doi.org/10.1007/s00259-024-06641-w
. (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([ 161 Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum.
Friebe, Liene, Freitag, Martin T., Braun, Martin, Nicolas, Guillaume, Bauman, Andreas, Bushnell, David, Christ, Emanuel, & Journal of Nuclear Medicine, 65, 228–235. https://doi.org/10.2967/jnumed.123.265894
. (2024). Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis.
Friebe, Liene, Freitag, Martin T., Braun, Martin, Nicolas, Guillaume, Bauman, Andreas, Bushnell, David, Christ, Emanuel, & Journal of Nuclear Medicine, 65, 228–235. https://doi.org/10.2967/jnumed.123.265894
. (2024). Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis.
European Journal of Nuclear Medicine and Molecular Imaging, 51(1), 183–195. https://doi.org/10.1007/s00259-023-06383-1
, Grønbæk, Henning, Navalkissoor, Shaunak, Haug, Alexander, Nicolas, Guillaume P., Pais, Ben, Ansquer, Catherine, Beauregard, Jean-Mathieu, McEwan, Alexander, Lassmann, Michael, Pennestri, Daniele, Volteau, Magali, Lenzo, Nat P., & Hicks, Rodney J. (2023). A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours.
European Journal of Nuclear Medicine and Molecular Imaging, 51(1), 183–195. https://doi.org/10.1007/s00259-023-06383-1
, Grønbæk, Henning, Navalkissoor, Shaunak, Haug, Alexander, Nicolas, Guillaume P., Pais, Ben, Ansquer, Catherine, Beauregard, Jean-Mathieu, McEwan, Alexander, Lassmann, Michael, Pennestri, Daniele, Volteau, Magali, Lenzo, Nat P., & Hicks, Rodney J. (2023). A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours.